(Geneva) – At the Stockholm Convention 8th Conference of the Parties (COP8), governments bowed to corporate influences in the listing decisions concerning two toxic chemicals under provisions of the treaty. Although delegates agreed to list the chemicals for global elimination, the decisions allow exemptions that extend industrial uses far into the future.
Geneva: Today, at the Stockholm Convention 8th Conference of the Parties, Chile and Canada surprised delegates by proposing to allow recycling materials containing a toxic flame retardant widely found in electronic waste (e-waste). The proposal violates the Stockholm Convention which explicitly prohibits recycling and reuse of substances on its list.
DecaBDE is used in the plastic casings of electronic products and if it is not removed, it is carried into new products when the plastic is recycled. Toxicity studies indicate potential adverse developmental, neurotoxic, and reproductive effects, and DecaBDE or its degradation products may also act as endocrine disruptors.
Ironically, a new IPEN study1 shows that the toxic recycling policy advocated by these countries widely contaminates children’s products. In fact, in Canada all sampled toys made of recycled plastic contained both OctaBDE and DecaBDE.
IPEN has released a Spring 2017 Catalog for its Toxic Toy Store booth at the Basel, Rotterdam and Stockholm Conferences of the Parties currently underway in Geneva, Switzerland. The exhibit booth highlights IPEN and Partner documents, and also displays toys from around the world that IPEN tested to determine potential toxic ingredients.
A survey of children’s products in 10 countries1 finds widespread contamination with an industrial chemical recommended for global prohibition. Short-chain chlorinated paraffins (SCCPs) are industrial chemicals primarily used in metalworking, but also as flame retardants and softeners in plastics. Their harmful properties have attracted global concern and a Stockholm Convention expert committee has recommended world-wide elimination of SCCPs under the treaty. SCCPs adversely affect the kidney, liver, and thyroid; disrupt endocrine function; and are anticipated to be human carcinogens.